The quest for safe and effective treatments of chronic hepatitis C in patients with kidney impairment-Reference-Cited by-同舟云学术

The quest for safe and effective treatments of chronic hepatitis C in patients with kidney impairment

Published:2016-05-13 Issue:6 Volume:36 Page:791-793
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

De Nicola Stella¹,Aghemo Alessio¹

Affiliation:

1. UO Gastroenterologia ed Epatologia; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano; Università degli Studi di Milano; Milan Italy

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13123/fullpdf

Reference19 articles.

1. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives;Asselah;Liver Int,2016

2. Treatment of hepatitis C virus genotype 1-infected patients: mission accomplished?;Puoti;Liver Int,2016

3. EASL recommendations on treatment of hepatitis C 2015;European Association for Study of Liver;J Hepatol,2015

4. Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy;Al Marzooqi;Liver Int,2015

5. Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis;Fabrizi;Dig Dis Sci,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?;Viruses;2021-06-01

2. Sofosbuvir in HCV patients with chronic kidney disease: No time for caution;Liver International;2021-03-17

3. Management of hepatitis C in a patient undergoing solid organ (kidney) transplant;Official Journal of the Association of Medical Microbiology and Infectious Disease Canada;2018-12

4. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN);Digestive and Liver Disease;2018-11

5. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN);Internal and Emergency Medicine;2018-09-25